WOBURN, Mass. (Sept. 20)—CardioTech International Inc. and Implant Sciences Corp. will jointly develop a urethane-covered stent to be used in the treatment of cardiovascular disease. Under terms of an agreement between the two firms, Implant Sciences will make the stents and ship them to CardioTech's plant in Woburn where CardioTech's patented urethane process is applied. No financial details were released.
CardioTech, Implant Sciences to make stent
Letter
to the
Editor
Rubber & Plastics News wants to hear from its readers. If you want to express your opinion on a story or issue, email your letter to Editor Bruce Meyer at [email protected].